Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of G3139 in Combination With Doxorubicin in Advanced Hepatocellular Carcinoma

NCT00047229 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00047229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00047229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of G3139 in Combination With Doxorubicin in Advanced Hepatocellular Carcinoma
Lead sponsor
University Health Network, Toronto
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2002
Completion date
April 30, 2009
Enrollment
27 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer